HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency.

AuthorsG A Van Norman, T Gernsheimer, W L Chandler, R P Cochran, B D Spiess
JournalJournal of cardiothoracic and vascular anesthesia (J Cardiothorac Vasc Anesth) Vol. 11 Issue 6 Pg. 760-3 (Oct 1997) ISSN: 1053-0770 [Print] United States
PMID9327320 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Plasminogen Activator Inhibitor 1
  • Antithrombin III
Topics
  • Antithrombin III (therapeutic use)
  • Antithrombin III Deficiency
  • Cardiopulmonary Bypass
  • Fibrinolysis (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: